AlphAIAlphAI — Financial news for AI agents
financialcontent.comSEP 142 min read$JBL

Why Jabil (JBL) Shares Are Plunging Today

Jabil (JBL) shares fell 5.1% after Goldman Sachs lowered its price target to $375, citing a more cautious valuation. The stock is volatile, down 22% from its 52-week high, but up 25.1% year-to-date. Higher bond yields and oil prices pose risks for the company.

Original reporting
financialcontent.com
Published Sep 14, 2026, 5:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 14, 2026, 6:46 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Why Jabil (JBL) Shares Are Plunging Today — source image
Source · financialcontent.com
Decision brief

The 30-second read

$JBLBearishMed
01

Why it matters

The analyst downgrade is the primary catalyst for today's price action, indicating heightened short‑term risk.

02

Market read

Analyst target cuts can quickly move mid‑cap stocks; traders should monitor further guidance and sector sentiment.

03

What to watch

Recent contract wins and a strong balance sheet were not highlighted in the downgrade.

Relevance 7/10Novelty 7/10Timing: afternoon session today

Background

Jabil is a leading electronics manufacturing services firm; its stock has been volatile with multiple >5% moves this year.

Company-level read

Ticker impact

$JBLBearishMedium confidence
Context

Goldman Sachs cut Jabil's price target to $375, triggering a 5.1% share decline in the afternoon session.

Expected impact

Potential further downside if target cut signals broader concerns.

Evidence & confidence

A 5% move on a target reduction suggests short‑term weakness; traders may consider short positions or wait for a bounce.

Market effects

Sector

The downgrade may pressure other EMS providers as investors reassess valuation multiples.

Regional

U.S. equities may see slight drag in the industrial/technology segment.

Global

Limited to markets tracking U.S. tech and manufacturing stocks.

Counterpoint

What could challenge this read

The target cut could be overly cautious; the stock may be undervalued at current levels.

Key entities

  • Analyst
    Goldman Sachs

    Reduced price target for Jabil to $375.

Read at source← All news

Related articles

SEP 11
$JBLMed

JBL Stock Rises as Goldman Sachs Backs AI Growth Story

Jabil Inc. (JBL) stock rose 5.65% after strong earnings guidance. Goldman Sachs, while cutting its target to $375, expects 50% AI revenue growth and 6% EBIT margins. JBL reported $8.75B revenue, $275M net income, and 3% profit margin. The stock is in an uptrend, with support at $300 and resistance around $340.

stockstotrade.com2 min
SEP 7
$JBLMedAI 8/10

Jabil Rises 36.2% Year to Date: Should You Buy the Stock?

Jabil Inc. (JBL) has risen 36.2% year-to-date, outperforming its industry and the S&P 500. The company expects AI-related revenues to reach $13.6B in fiscal 2026, up from $9B in 2025, and is expanding manufacturing capacity to meet demand. JBL also sees growth in healthcare, renewable energy, and digital commerce sectors, but faces supply chain and competition challenges.

finance.yahoo.com2 min
SEP 4
$JBLHighAI 8/10

FDA Contamination Warning Could Be A Game Changer For Jabil’s (JBL) Pharma Ambitions

The FDA issued a warning to Jabil's Pharmaceutics International facility, citing significant violations of sterile drug manufacturing practices, including fungal contamination and weak quality oversight. This raises concerns about Jabil's ability to manufacture sterile products and could impact its pharmaceutical expansion plans. Jabil's 2026 revenue guidance of $35 billion includes contributions from healthcare and pharma, which may now be questioned by investors.

simplywall.st3 min
AUG 20
$JBLHighAI 8/10

Jabil Stock: Is Wall Street Bullish or Bearish?

Jabil Inc. (JBL), a $33.8B electronic manufacturing services provider, reported Q3 2026 adjusted EPS of $3.16 and revenue of $8.75B, exceeding expectations. The company raised its fiscal 2026 guidance, citing strong AI data-center demand and new partnerships. Shares have surged 58.6% over 52 weeks, outperforming the S&P 500. Analysts rate it a 'Strong Buy' with a mean price target of $451.18.

barchart.com2 min
AUG 11
$JBLMed

Jabil upgraded by UBS as AI demand, healthcare growth support outlook

UBS upgraded Jabil Inc (JBL) to Buy and raised estimates, saying a multiyear growth cycle is supported by AI investment, healthcare demand, and expanding automation and robotics. UBS set a $430 price target and lowered its valuation multiple to about 22x. It forecasts AI revenue growth to about $20.3B in FY2027, raised EPS to $16.78 (FY2027) and $20.24 (FY2028).

proactiveinvestors.com4 min
AUG 11
$JBLMed

Stocks making the biggest moves midday: Jabil, AppLovin, Apollo, SpaceX, Upwork & more

Midday movers included Jabil, up 5% after a UBS upgrade to Buy, and AppLovin, down 5% after Bank of America downgraded to neutral and cut its price target to $400. Aramark rose 9% after Q3 beat and raised forecast. Under Armour fell 8% on a Barclays downgrade. Upwork dropped 13% on weaker guidance. Fermi jumped 22% after a first binding lease with TensorWave for 222 MW and about $6.5B contracted revenue.

cnbc.com7 min